436-450 of 894
Phase-3 SunRISe-2: TAR-200 Plus Cetrelimab Versus Chemoradiotherapy in Muscle-Invasive Bladder Cancer
Oncology and HematologyPhase-3 SunRISe-2: TAR-200 Plus Cetrelimab Versus Chemoradiotherapy in Muscle-Invasive Bladder Cancer
Updates from Apa-RP: Apalutamide and ADT in High-Risk Localized Prostate Cancer
Oncology and HematologyUpdates from Apa-RP: Apalutamide and ADT in High-Risk Localized Prostate Cancer
Real-World Sequencing and Survival in Locally Advanced Prostate Cancer
Oncology and HematologyReal-World Sequencing and Survival in Locally Advanced Prostate Cancer
Evolving Trends in Germline Genetic Testing for Prostate Cancer
Oncology and HematologyEvolving Trends in Germline Genetic Testing for Prostate Cancer
AEGEAN Trial: The Role of Perioperative Durvalumab in NSCLC
Project Oncology®AEGEAN Trial: The Role of Perioperative Durvalumab in NSCLC
Treating mCRPC with Lutetium-177 and Radium-223: Expert Insights
Project Oncology®Treating mCRPC with Lutetium-177 and Radium-223: Expert Insights
Alan Bryce, MD
- advertisement
Cannabis Extract and Melanoma: Insights into Cell Death Mechanisms
DermConsultCannabis Extract and Melanoma: Insights into Cell Death Mechanisms
mCRPC Care: Reducing Progression Risk by Combining Enzalutamide and Talazoparib
Project Oncology®mCRPC Care: Reducing Progression Risk by Combining Enzalutamide and Talazoparib
Charles Turck, PharmD, BCPS, BCCCP
Neeraj Agarwal, MD, FASCO
Prostate Cancer Research: Why Disparities Exist in Mortality and Trial Access
Project Oncology®Prostate Cancer Research: Why Disparities Exist in Mortality and Trial Access
Rishi Sekar, MD
Novel Immune Checkpoint Strategies in Non-Small Cell Lung Cancer Care
Project Oncology®Novel Immune Checkpoint Strategies in Non-Small Cell Lung Cancer Care
Jacob Sands, MD
Aakesh Desai, MD, MPH
Prostate Cancer Care: Improving Hormonal Therapy Sequencing Post-Treatment Intensification
Project Oncology®Prostate Cancer Care: Improving Hormonal Therapy Sequencing Post-Treatment Intensification
Zachery Reichert MD, PhD
The Necessity of a Multidisciplinary Approach Through the mCRPC Treatment Journey
Project Oncology®The Necessity of a Multidisciplinary Approach Through the mCRPC Treatment Journey
Jessica E. Hawley M.D. M.S.
- advertisement
Prostate Cancer Care: Overcoming Challenges in Delivering Germline Testing to Veterans
Project Oncology®Prostate Cancer Care: Overcoming Challenges in Delivering Germline Testing to Veterans
Daniel Kwon, MD
ASCO GU 2024: Reviewing Updated Practice Guidelines for Prostate Cancer
Project Oncology®ASCO GU 2024: Reviewing Updated Practice Guidelines for Prostate Cancer
Jessica E. Hawley M.D. M.S.
Treating High-Risk Biochemically Recurrent Prostate Cancer: An Update from ASCO-GU
Project Oncology®Treating High-Risk Biochemically Recurrent Prostate Cancer: An Update from ASCO-GU
Neal Shore, MD, FACS
